Publications by authors named "Natalie Maimon"

Claim this Profile
A
ALK Inhibitors or Chemotherapy for Third Line in ALK-positive NSCLC? Real-world Data.
Mor Moskovitz, Elizabeth Dudnik, Sivan Shamai, Yakir Rotenberg, Noa Popovich-Hadari, Natalie Maimon

Oncologist· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin Use and Outcome of Sunitinib Treatment in Patients With Diabetes and Metastatic Renal Cell Carcinoma.
Daniel Keizman, Maya Ish-Shalom, Avishay Sella, Maya Gottfried, Natalie Maimon

Clin Genitourin Cancer· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is there a "Trial Effect" on Outcome of Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib?
Daniel Keizman, Keren Rouvinov, Avishay Sella, Maya Gottfried, Natalie Maimon

Cancer Res Treat· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[THE CURRENT APPROACH TO METASTATIC RENAL CELL CARCINOMA].
Daniel Keizman, Natalie Maimon, Moshe Mishaeli, Iryna Kuchuk, Maya Gottfried

Harefuah· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic hormone refractory prostate cancer: recent advances in standard treatment paradigm, and future directions.
Daniel Keizman, Natalie Maimon, Maya Gottfried

Am J Clin Oncol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experience with sunitinib treatment for metastatic renal cell carcinoma in a large cohort of Israeli patients: outcome and associated factors.
Dana Livne-Segev, Maya Gottfried, Natalie Maimon, Avivit Peer, Avivit Neumann

Isr Med Assoc J· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are bisphosphonates an indispensable tool in the era of targeted therapy for renal cell carcinoma and bone metastases?
Daniel Keizman, Maya Ish-Shalom, Natalie Maimon, Maya Gottfried

World J Urol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active smoking may negatively affect response rate, progression-free survival, and overall survival of patients with metastatic renal cell carcinoma treated with sunitinib.
Daniel Keizman, Maya Gottfried, Maya Ish-Shalom, Natalie Maimon, Avivit Peer

Oncologist· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretreatment neutrophil-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with ketoconazole: association with outcome and predictive nomogram.
Daniel Keizman, Maya Gottfried, Maya Ish-Shalom, Natalie Maimon, Avivit Peer

Oncologist· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Metastatic hormone refractory prostate cancer: new treatment horizon].
Daniel Keizman, Natalie Maimon, Maya Gottfried

Harefuah· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinoma.
Daniel Keizman, Maya Ish-Shalom, Roberto Pili, Hans Hammers, Mario A Eisenberger, Natalie Maimon

Eur J Cancer· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An animal model for chemotherapy-associated steatohepatitis and its prevention by the oral administration of fatty acid bile acid conjugate.
Daniel Keizman, Natalie Maimon, Maya Ish-Shalom, Dana Buchbut, Moshe Inbar

Cancer· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression and significance of EGFR in malignant peripheral nerve sheath tumor.
Daniel Keizman, Josephine Issakov, Isaac Meller, Natalie Maimon, Maya Ish-Shalom

J Neurooncol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant treatment with paclitaxel and epirubicin in invasive breast cancer: a phase II study.
David Sarid, Ilan G Ron, Fani Sperber, Yona Stadler, Perry Kahan, Natalie Maimon

Clin Drug Investig· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis